{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Drug+Evaluation&page=2", "query": { "condition": "Drug Evaluation", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Drug+Evaluation&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-05-22T07:50:29.304Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00198419", "title": "Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Drug Hypersensitivity" ], "interventions": [ { "name": "Vitrase", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bausch & Lomb Incorporated", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 65, "start_date": "2004-03", "completion_date": "2004-03", "has_results": false, "last_update_posted_date": "2013-03-14", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 1, "location_summary": "Davis, California", "locations": [ { "city": "Davis", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00198419" }, { "nct_id": "NCT00591266", "title": "Efficacy and Safety of Azilsartan Medoxomil, Once Daily (QD), Co-Administered With Amlodipine in Participants With Essential Hypertension", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Hypertension" ], "interventions": [ { "name": "Azilsartan Medoxomil and amlodipine", "type": "DRUG" }, { "name": "Amlodipine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Takeda", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 566, "start_date": "2007-10", "completion_date": "2009-04", "has_results": true, "last_update_posted_date": "2011-07-22", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 50, "location_summary": "Mesa, Arizona • Phoenix, Arizona • Anaheim, California + 47 more", "locations": [ { "city": "Mesa", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Anaheim", "state": "California" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00591266" }, { "nct_id": "NCT07318051", "title": "Sample Collection for Ongoing Research and Product Evaluation Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Breast Cancer", "Lung Cancer", "Muscle Invasive Bladder Cancer", "Rectal Cancer", "Pancreatic Cancer", "Ovarian Cancer", "Gastroesophageal Cancer", "Prostate Cancer", "Melanoma", "Head and Neck Cancer", "Uterine Cancer", "Liver Cancer" ], "interventions": [], "intervention_types": [], "sponsor": "Natera, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 9600, "start_date": "2025-07-21", "completion_date": "2035-01", "has_results": false, "last_update_posted_date": "2026-01-15", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 1, "location_summary": "Austin, Texas", "locations": [ { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07318051" }, { "nct_id": "NCT01747772", "title": "Sonoelastography: Ultrasound Method to Measure Liver Fibrosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Liver Disease", "Non-Alcoholic Fatty Liver Disease", "Hepatitis C Virus (HCV) Coinfection", "Hepatitis B Virus (HBV)", "Drug-Induced Liver Injury" ], "interventions": [ { "name": "Shear Wave Sonoelastography", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Massachusetts General Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 180, "start_date": "2010-02", "completion_date": "2014-02-14", "has_results": true, "last_update_posted_date": "2017-06-14", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01747772" }, { "nct_id": "NCT00002270", "title": "A Pilot Study of the Efficacy of Recombinant Alpha Interferon (IFN-A2b) and Zidovudine (AZT) in the Treatment of Progressive Multifocal Leukoencephalopathy (PML) Complicating HIV-1 Infection", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "HIV Infections", "Leukoencephalopathy, Progressive Multifocal" ], "interventions": [ { "name": "Interferon alfa-2b", "type": "DRUG" }, { "name": "Zidovudine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Miami", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": null, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2005-06-24", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 1, "location_summary": "Miami, Florida", "locations": [ { "city": "Miami", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002270" }, { "nct_id": "NCT05526157", "title": "An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 Diabetes Are Treated and How the Introduction of New Treatment Options, Like Finerenone, Impacts Clinical Practice", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Chronic Kidney Disease", "Type 2 Diabetes Mellitus" ], "interventions": [ { "name": "Finerenone (Kerendia, BAY 948862)", "type": "DRUG" }, { "name": "Sodium-glucose cotransporter 2 inhibitors (SGLT2i)", "type": "DRUG" }, { "name": "Glucagon-like peptide-1 receptor agonists (GLP 1 RA)", "type": "DRUG" }, { "name": "Steroidal mineral corticoid receptor antagonists (sMRA)", "type": "DRUG" }, { "name": "Non-steroidal mineral corticoid receptor antagonists (nsMRA)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50000, "start_date": "2022-10-01", "completion_date": "2024-09-05", "has_results": false, "last_update_posted_date": "2024-10-15", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 1, "location_summary": "Eden Prairie, Minnesota", "locations": [ { "city": "Eden Prairie", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT05526157" }, { "nct_id": "NCT00853320", "title": "Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "Oxycodone hydrochloride tablet 15 mg", "type": "DRUG" }, { "name": "Roxicodone™ tablet 15 mg", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 38, "start_date": "2003-02", "completion_date": "2003-02", "has_results": false, "last_update_posted_date": "2016-10-19", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 1, "location_summary": "Saint Charles, Missouri", "locations": [ { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00853320" }, { "nct_id": "NCT02904629", "title": "Evaluation of Respecting the Circle of Life on Pregnancy Prevention Outcomes Among American Indian Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Sex", "Unprotected Sex", "Contraception", "Alcohol Use", "Drug Use", "Pregnancy" ], "interventions": [ { "name": "Respecting the Circle of Life (RCL)", "type": "BEHAVIORAL" }, { "name": "Control Program", "type": "OTHER" } ], "intervention_types": [ "BEHAVIORAL", "OTHER" ], "sponsor": "Johns Hopkins Bloomberg School of Public Health", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "11 Years", "maximum_age": null, "sex": "ALL", "summary": "11 Years and older" }, "enrollment_count": 1072, "start_date": "2016-05", "completion_date": "2022-04", "has_results": false, "last_update_posted_date": "2022-07-19", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 1, "location_summary": "Whiteriver, Arizona", "locations": [ { "city": "Whiteriver", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT02904629" }, { "nct_id": "NCT03735680", "title": "A Study to Evaluate ONM-100, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Cancer", "Head and Neck Squamous Cell Carcinoma", "Colorectal Cancer", "Prostate Cancer", "Ovarian Cancer", "Urothelial Carcinoma", "Non-small Cell Lung Cancer" ], "interventions": [ { "name": "ONM-100", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OncoNano Medicine, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2019-08-09", "completion_date": "2021-11-18", "has_results": true, "last_update_posted_date": "2023-07-07", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 3, "location_summary": "Philadelphia, Pennsylvania • Dallas, Texas • Houston, Texas", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Dallas", "state": "Texas" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT03735680" }, { "nct_id": "NCT05061979", "title": "A Study to Evaluate the Pharmacokinetics (How it Moves Into, Through and Out From the Body) of a New Gadolinium-based Contrast Agent (GBCA) After Injection and How Safe it is in Participants With Normal and Impaired Renal Function", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Contrast Enhancement in Magnetic Resonance Imaging" ], "interventions": [ { "name": "BAY1747846", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 24, "start_date": "2021-10-12", "completion_date": "2022-07-14", "has_results": false, "last_update_posted_date": "2022-11-21", "last_synced_at": "2026-05-22T07:50:29.304Z", "location_count": 2, "location_summary": "Miami, Florida • Knoxville, Tennessee", "locations": [ { "city": "Miami", "state": "Florida" }, { "city": "Knoxville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT05061979" } ] }